ClassID:

94408

C07D233/42 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Oxygen or sulfur atoms Sulfur atoms

Recent Application in this class:
#1
20250388595
2025-12-25

MODULATORS OF EUKARYOTIC INITIATION FACTOR 2B, COMPOSITIONS AND METHODS

#2
20250368608
2025-12-04

SELECTIVE HDAC6 INHIBITOR

#3
20250034096
2025-01-30

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#4
20230331681
2023-10-19

Compounds and methods for the targeted degradation of androgen receptor

#5
20230219898
2023-07-13

COMPOUNDS AND METHODS FOR BLOCKING APOPTOSIS AND INDUCING AUTOPHAGY

#6
20220411433
2022-12-29

Modulators of eukaryotic initiation factor 2B, compositions and methods

#7
20220259154
2022-08-18

Compounds and methods for the targeted degradation of androgen receptor

#8
20210171470
2021-06-10

Compounds and methods for the targeted degradation of androgen receptor

#9
20210147435
2021-05-20

Modulators of eukaryotic initiation factor 2B, compositions and methods

#10
20210040044
2021-02-11

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#11
20210009528
2021-01-14

Compounds and methods for the targeted degradation of androgen receptor

#12
20200095205
2020-03-26

Compounds and methods for the targeted degradation of androgen receptor

#13
20200031777
2020-01-30

Substituted imidazolium sulfuranes and their use

#14
20190290632
2019-09-26

Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

#15
20180346392
2018-12-06

THIOETHER COMPOUNDS AS NITRIFICATION INHIBITORS

#16
20180134633
2018-05-17

Thioether compounds as nitrification inhibitors

#17
20180099940
2018-04-12

Compounds and methods for the targeted degradation of androgen receptor

#18
20150225755
2015-08-13

Ergothioneine production through metabolic engineering

#19
20150224107
2015-08-13

Dihydropyrimidin-2(1H)-one compounds as -nitrosoglutathione reductase inhibitors

#20
20150111875
2015-04-23

Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

#21
20140256701
2014-09-11

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

#22
20140235640
2014-08-21

Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors

#23
20130303784
2013-11-14

Method for preparing and using aminoethyl imidazolidinone and the thiocarbonyl thereof

#24
20130023667
2013-01-24

Method for preparing aminoethyl imidazolidinone or the thiocarbonyl thereof

#25
20120208817
2012-08-16

Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors

#26
20120202854
2012-08-09

4-substituted phenoxyphenylacetic acid derivatives

#27
20120142912
2012-06-07

Polycyclic compounds, termed calixurenes, and uses thereof

#28
20120108822
2012-05-03

Process for the preparation of chalcogene compounds

#29
20120077796
2012-03-29

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

#30
20110275719
2011-11-10

Trifluoromethylsulfonamide gamma secretase inhibitor

#31
20110223093
2011-09-15

IONIC LIQUID SYSTEMS FOR CARBON DIOXIDE AND SULFUR DIOXIDE REMOVAL

#32
20110130391
2011-06-02

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

#33
20100234365
2010-09-16

Compounds and compositions as inhibitors of cannabinoid receptor 1 activity

#34
20100210696
2010-08-19

5-Membered heterocyclic compound

#35
20100173955
2010-07-08

4-substituted phenoxyphenylacetic acid derivatives

#36
20100143805
2010-06-10

NITROXIDES FOR LITHIUM-ION BATTERIES

#37
20100004241
2010-01-07

NON-IMIDAZOLE ARYLOXYALKYLAMINES

#38
20090176766
2009-07-09

Imidazolidinone and imidazolidinethione derivatives

#39
20090018180
2009-01-15

2-imidazolines

#40
20080312287
2008-12-18

Compound and Methods For the Treatment of Cancer and Malaria

#41
20080306085
2008-12-11

NON-IMIDAZOLE ARYLOXYALKYLAMINES

#42
20080275233
2008-11-06

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

#43
20080269217
2008-10-30

Melanocortin-4 receptor binding compounds and methods of use thereof

#44
20080255218
2008-10-16

Melanin-concentrating hormone receptor antagonists and methods of use

#45
20080153892
2008-06-26

Inhibitors of glutaminyl cyclase

#46
20080139811
2008-06-12

Retroviral protease inhibiting compounds

#47
20080132550
2008-06-05

Heterocyclic compounds as P2X7 ion channel blockers

#48
20080113975
2008-05-15

THIOUREA COMPOUNDS

#49
20080096875
2008-04-24

THIOUREA COMPOUNDS

#50
20080090855
2008-04-17

Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators

#51
20070208070
2007-09-06

Ion channel modulators

#52
20070190523
2007-08-16

Method and compositions for identifying anti-hiv therapeutic compounds

#53
20070010489
2007-01-11

Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds

#54
20060235049
2006-10-19

Non-imidazole aryloxyalkylamines

#55
20060223829
2006-10-05

Hydroxysteroid dehydrogenase inhibitors

#56
20060167065
2006-07-27

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

#57
20060135601
2006-06-22

Hexafluoroisopropanol substituted cyclohexane derivatives

#58
20060128692
2006-06-15

Non nucleoside reverse transcriptase inhibitors

#59
20060122400
2006-06-08

Method of making imidazole-2-thiones

#60
20060115815
2006-06-01

Method and compositions for identifying anti-hiv therapeutic compounds

#61
20060014836
2006-01-19

Substituted aryl thioureas and related compounds; inhibitors of viral replication

#62
20060009528
2006-01-12

Cannabinoid receptor ligands

#63
20060004059
2006-01-05

Substituted heterocycles for the treatment of diabetes and other diseases

#64
20050239054
2005-10-27

Method and compositions for identifying anti-HIV therapeutic compounds

#65
20050227979
2005-10-13

Non-imidazole aryloxypiperidines

#66
20050215783
2005-09-29

Thiourea compositions and uses thereof

#67
20050209197
2005-09-22

Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds

#68
20050197320
2005-09-08

Non nucleoside reverse transcriptase inhibitors

#69
20050124682
2005-06-09

Substituted cyclic compounds

#70
20050112693
2005-05-26

Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof

#71
20050070581
2005-03-31

Imidazolidinedione derivatives for the treatment of diabetes and other diseases

#72
20050059729
2005-03-17

Substituted cyclic compounds

#73
20050026916
2005-02-03

Heterocyclic compounds as P2X7 ion channel blockers